Dan Littman

Dan Littman

Director/Miembro de la Junta en PFIZER INC. .

Fortuna: - $ al 31/05/2026

73 años
Health Technology
Consumer Services
Commercial Services

Perfil

Dan R.
Littman
is the founder of Vedanta Biosciences, Inc., founded in 2010; Orca Pharmaceuticals Ltd., founded in 2012; and Immunai, Inc., founded in 2018.
Dr. Littman currently serves as an Independent Director at Pfizer Inc. since 2018, is a member of the Scientific Advisory Board at ChemoCentryx, Inc., a member of the National Academy of Sciences, a member of the National Academy of Medicine (United States), a Venture Partner at Catalio Capital Management LP, and a Professor at NYU Langone Health since 1995.
Dr. Littman was a Professor at The University of California, San Francisco from 1985 to 1995.
Dr. Littman completed undergraduate education at Princeton University and earned a doctorate from Washington University School of Medicine.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
23/04/2026 0 ( -.--% ) - $ 31/05/2026

Cargos activos de Dan Littman

EmpresasCargoInicio
PFIZER INC. Director/Miembro de la Junta 05/03/2018
CHEMOCENTRYX, INC. Consultor / Asesor -
Fundador 01/01/2010
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal 01/01/1995
Fundador 01/12/2018
Inversor de Capital Privado -

Antiguos cargos conocidos de Dan Littman.

EmpresasCargoFin
Corporate Officer/Principal 01/01/1995
░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ -
Ver el detalle de la experiencia de Dan Littman.

Formación de Dan Littman.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

94

Relaciones de 1er grado

12

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas12

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Health Services

Consumer Services

Technology Services

Finance

-40%: ¡Descubre las mejores inversiones del futuro con las herramientas para suscriptores!
d
:
:
APROVECHAR LA PROMOCIÓN